Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gallium-68 NY 108 - Norroy Bioscience

Next Previous
X
Search
Drug Profile

Gallium-68 NY 108 - Norroy Bioscience

Alternative Names: 68Ga-NYM-032; 68Ga-NYM032 PET/CT; Gallium-68 NY-108; Gallium-68 NY108 PET/CT; Gallium-68 NYM 032

Latest Information Update: 05 Sep 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Norroy Bioscience
  • Class Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics; Small molecules
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Prostate cancer

Most Recent Events

  • 05 Sep 2024 Phase-I/II clinical trials in Prostate cancer (Diagnosis) in China (IV) prior to September 2024 (Norroy Bioscience Pipeline, September 2024)
  • 24 Apr 2024 Phase-I clinical trials in Prostate cancer (Diagnosis) in China (IV) (NCT06389695)
  • 11 Feb 2024 US FDA approves IND application for Gallium-68 NY 108 in Prostate cancer

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top